Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Incidence, Risk Factors, and Survival Implications of Immune-Related Adverse Events in Patients With Metastatic Breast Cancer.
Journal: Clinical breast cancer
Published: March 20, 2026
Safety and clinical outcomes of pembrolizumab standard-interval dosing versus extended-interval dosing in patients with breast cancer.
Journal: The oncologist
Published: August 27, 2025
The Current State of Bispecific Antibodies and T-Cell Directed Therapy in NHL.
Journal: Cancers
Published: February 02, 2025
Showing 1-3 of 3
Last Updated: 09/26/2026